paromomycin has been researched along with Sensitivity and Specificity in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (14.29) | 18.2507 |
| 2000's | 5 (71.43) | 29.6817 |
| 2010's | 1 (14.29) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| C P, A; Leszczynski, J; Melge, AR; Mohan, CG; Sizochenko, N; Subhramanian, S | 1 |
| Keller, E; Klausz, G; Laczay, P; Róna, K; Shem-Tov, M; Szakay, M; Székely-Körmöczy, P | 1 |
| Blount, KF; Hermann, T; Tor, Y; Zhao, F | 1 |
| Han, KC; Yang, EG; Yu, J | 1 |
| Georgiou, CD; Konstantinidis, TC; Patsoukis, N; Synetos, D | 1 |
| Pandey, HP; Singh, RK; Sundar, S | 1 |
| Cwik, M; Kanyok, T; Lu, J | 1 |
1 review(s) available for paromomycin and Sensitivity and Specificity
| Article | Year |
|---|---|
Visceral leishmaniasis (kala-azar): challenges ahead.
Topics: Aminoquinolines; Amphotericin B; Animals; Antimony; Antiprotozoal Agents; Drug Resistance; Enzyme-Linked Immunosorbent Assay; Humans; India; Leishmania; Leishmaniasis, Visceral; Lipids; Paromomycin; Public Health; Sensitivity and Specificity | 2006 |
6 other study(ies) available for paromomycin and Sensitivity and Specificity
| Article | Year |
|---|---|
Multiple e-Pharmacophore modeling to identify a single molecule that could target both streptomycin and paromomycin binding sites for 30S ribosomal subunit inhibition.
Topics: Binding Sites; Catalytic Domain; Drug Discovery; Ligands; Microbial Sensitivity Tests; Molecular Docking Simulation; Molecular Dynamics Simulation; Molecular Structure; Paromomycin; Protein Binding; Quantitative Structure-Activity Relationship; Reproducibility of Results; Ribosome Subunits, Small, Bacterial; Sensitivity and Specificity; Streptomycin | 2019 |
Determination of paromomycin residues in turkey tissues by liquid chromatography/mass spectrometry.
Topics: Animals; Anti-Bacterial Agents; Chromatography, Liquid; Drug Residues; Kidney; Liver; Mass Spectrometry; Muscles; Paromomycin; Sensitivity and Specificity; Turkeys | 2009 |
Conformational constraint as a means for understanding RNA-aminoglycoside specificity.
Topics: Aminoglycosides; Anti-Bacterial Agents; Binding Sites; Carbohydrate Sequence; Drug Design; Endoribonucleases; HIV Long Terminal Repeat; HIV-1; Ligands; Models, Molecular; Molecular Conformation; Molecular Sequence Data; Neomycin; Paromomycin; Protein Structure, Tertiary; RNA; Sensitivity and Specificity; Spectrum Analysis; Structure-Activity Relationship | 2005 |
Quantitative analysis of shape-specific interactions of Rev response element with a positively charged Rev peptide by capillary electrophoresis.
Topics: Amino Acid Sequence; Base Sequence; Binding, Competitive; Buffers; Electrophoresis, Capillary; Framycetin; Gene Products, rev; Genes, env; Inhibitory Concentration 50; Paromomycin; Peptide Fragments; Sensitivity and Specificity | 2005 |
Translational fidelity mutations in 18S rRNA affect the catalytic activity of ribosomes and the oxidative balance of yeast cells.
Topics: Base Sequence; Binding Sites; Catalysis; Codon, Terminator; Dose-Response Relationship, Drug; Gene Expression Regulation; Models, Biological; Molecular Sequence Data; Mutation; Oxidation-Reduction; Paromomycin; Peptide Chain Initiation, Translational; Peptides; Peptidyl Transferases; Protein Biosynthesis; Protein Modification, Translational; Ribosomes; RNA, Ribosomal, 18S; RNA, Transfer, Amino Acyl; Saccharomyces cerevisiae; Sensitivity and Specificity; Suppression, Genetic; Time Factors | 2006 |
Determination of paromomycin in human plasma and urine by reversed-phase high-performance liquid chromatography using 2,4-dinitrofluorobenzene derivatization.
Topics: Anti-Bacterial Agents; Chromatography, High Pressure Liquid; Dinitrofluorobenzene; Humans; Paromomycin; Reproducibility of Results; Sensitivity and Specificity; Spectrophotometry, Ultraviolet | 1997 |